Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Zeo ScientifiX's operating income for the twelve months ending Apr 30, 2026 was -$4.13M. For fiscal 2025 it was -$5.39M. The highest annual figure on record is -$744.31K in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | -$5.39M | – |
| FY2024 | Oct 31, 2024 | -$5.32M | – |
| FY2023 | Oct 31, 2023 | -$6.77M | – |
| FY2022 | Oct 31, 2022 | -$8.84M | – |
| FY2021 | Oct 31, 2021 | -$12.74M | – |
| FY2020 | Oct 31, 2020 | -$12.44M | – |
| FY2019 | Oct 31, 2019 | -$1.78M | – |
| FY2018 | Oct 31, 2018 | -$3.49M | – |
| FY2017 | Oct 31, 2017 | -$8.64M | – |
| FY2016 | Oct 31, 2016 | -$1.04M | – |
| FY2015 | Oct 31, 2015 | -$744.31K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$512.00K | – |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | -$878.00K | – |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | -$668.00K | – |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | -$2.07M | – |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | -$1.39M | – |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | -$1.25M | – |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | -$1.56M | – |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | -$1.16M | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | -$1.23M | – |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | -$1.45M | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | -$3.18M | – |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | -$2.76M | – |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | -$1.26M | – |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | -$1.64M | – |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | -$952.38K | – |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | -$1.39M | – |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | -$5.15M | – |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | -$5.25M | – |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | -$1.36M | – |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | -$688.79K | – |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | -$710.74K | – |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | -$339.14K | – |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | -$418.44K | – |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | -$301.45K | – |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | -$2.36M | – |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | -$414.62K | – |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | -$897.47K | – |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | -$901.42K | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | -$2.60M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | -$4.24M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | -$425.18K | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | -$163.12K | – |
| Q2 FY2016CQ1 2016 | Apr 30, 2016 | -$256.27K | – |
| Q1 FY2016CQ4 2015 | Jan 31, 2016 | -$198.75K | – |
| Q4 FY2015CQ3 2015 | Oct 31, 2015 | -$324.22K | – |
| Q3 FY2015CQ2 2015 | Jul 31, 2015 | -$381.98K | – |
See a number that looks wrong?